What this was
On the Amendment S.Amdt. 5336 to S.Con.Res. 33 (No short title on file). To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.